Publications by authors named "J Jan B van Lanschot"

Claim this Profile
T
The value of routine endoscopic ultrasound in patients with esophageal cancer after neoadjuvant chemoradiotherapy undergoing active surveillance.
Sanjiv S G Gangaram Panday, Matteo Pittacolo, Sjoerd Lagarde, Bianca Mostert, Judith Honing, J Jan B van Lanschot

Endoscopy· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of Predicting Residual Disease and Disease Progression During Active Surveillance for Esophageal Cancer.
Sanjiv S G Gangaram Panday, David van Klaveren, Sjoerd M Lagarde, Hester F Lingsma, Bianca Mostert, J Jan B van Lanschot

Ann Surg Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of surveillance endoscopy and EUS of the esophagus after neoadjuvant chemoradiotherapy: Results from the (pre)SANO trial.
Sanjiv S G Gangaram Panday, Low Kuan Yean, Tanya M Bisseling, Wouter L Curvers, Jolanda M van Dieren, J Jan B van Lanschot

Endosc Int Open· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA detects residual disease after neoadjuvant chemoradiotherapy and guides adjuvant therapy in esophageal squamous cell carcinoma.
Zhichao Liu, Guoqiang Wang, Yang Yang, Yuchen Su, Hong Zhang, J Jan B van Lanschot

Cell Rep Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SANO trial: innovations, risks, and unanswered questions - Authors' reply.
Berend J van der Wilk, Ben M Eyck, Sjoerd M Lagarde, Bas P L Wijnhoven, J Jan B van Lanschot

Lancet Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis